Menu Back toSession 10: Track A: Considering the Implications of International Differences in Regulation on Life Science Advertising and Promotions Regulatory Affairs

Advertising and Promotion Regulatory Affairs Conference

This event is now offered in a new entirely virtual format.


Session 10: Track A: Considering the Implications of International Differences in Regulation on Life Science Advertising and Promotions Regulatory Affairs

Session Chair(s)

Ratinder  Dhami, MS, RAC

Ratinder Dhami, MS, RAC

  • Director, Regulatory Affairs
  • Network Partners, United States
Industry creates global marketing strategies for healthcare products but navigating the different adverting and promotional requirements across regions can be difficult. This session will discuss the similarities and differences in the regulations that govern Direct to Consumer Advertising (DTCA) for medical devices in Canada, EU, and US. Presenters will describe key principles for advertising strategies in a global market and provide an overview of the process and procedures that affect international reviews.
Learning Objective :

Upon completion of this session, the participant should be able to:

  • Identify similarities and differences for advertising and promotion requirements in Canada, US, and EU
  • Determine when and how to use a core claims document
  • Evaluate how the review process for promotional material varies between regions, therapeutic area, and classification

Speaker(s)

John  Wong, MPharm

Optimizing Product Launch in Canada

John Wong, MPharm

  • TPIreg/Innomar Strategies, Canada
Madhavi  Bellamkonda, MSc

Navigating International Waters for Social Media and DTCA

Madhavi Bellamkonda, MSc

  • Director Regulatory Affairs, Advertising & Promotion
  • Abbott, United States

Contact us